Capsules combining HMG-CoA reductase inhibitor with antiplatelet P2Y12 inhibitor, utilized in post-acute coronary syndrome therapy. Sourced from generic drug suppliers, procured by hospital pharmacies, cardiovascular units, and community health centers for distribution to prescribing physicians.